What's Happening?
Symeres has appointed Gabriella Gentile as Chief Operating Officer, supporting its transatlantic growth ambitions. Gabriella brings over 25 years of experience in the pharmaceutical and medical device industries, with expertise in operational performance and change management.
Why It's Important?
Gabriella's appointment is a strategic move to enhance Symeres' global operations, aligning business processes with performance outcomes. Her leadership is expected to drive Symeres' growth, reinforcing its position as a global biotechnology leader.
What's Next?
Gabriella will focus on expanding Symeres' capabilities across the pharmaceutical value chain, supporting the development of next-generation therapies. Her role will involve aligning operations with customer satisfaction and quality standards.
